Format

Send to

Choose Destination
Nat Biotechnol. 2018 Nov;36(10):971-976. doi: 10.1038/nbt.4203. Epub 2018 Sep 24.

Conversion of staphylococcal pathogenicity islands to CRISPR-carrying antibacterial agents that cure infections in mice.

Author information

1
Departments of Microbiology and Medicine, New York University School of Medicine, New York, New York, USA.

Abstract

Staphylococcus aureus and other staphylococci continue to cause life-threatening infections in both hospital and community settings. They have become increasingly resistant to antibiotics, especially β-lactams and aminoglycosides, and their infections are now, in many cases, untreatable. Here we present a non-antibiotic, non-phage method of treating staphylococcal infections by engineering of the highly mobile staphylococcal pathogenicity islands (SaPIs). We replaced the SaPIs' toxin genes with antibacterial cargos to generate antibacterial drones (ABDs) that target the infecting bacteria in the animal host, express their cargo, kill or disarm the bacteria and thus abrogate the infection. Here we have constructed ABDs with either a CRISPR-Cas9 bactericidal or a CRISPR-dCas9 virulence-blocking module. We show that both ABDs block the development of a murine subcutaneous S. aureus abscess and that the bactericidal module rescues mice given a lethal dose of S. aureus intraperitoneally.

PMID:
30247487
DOI:
10.1038/nbt.4203

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center